In-silico Approaches to Study Therapeutic Efficacy of Nutraceuticals

  • Ramesh Kumar
  • Amit Kumar Singh
  • Ashutosh Gupta
  • Abhay K. Pandey


Medicinal plants are sources of bioactive compounds for curing ailments since ages. In absence of modern analytical techniques during earlier period, characterization of plant bioactive metabolites was a difficult task, which has now become possible with the innovation in analytical methods. The emerging databases of medicinal plants rich in phytochemical data with bioinformatics and cheminformatics techniques have shown to be advantageous tools for drug discovery. Owing to rising trend of bioactivity databases, the practice of using computational tools for prediction of protein targets of small molecules has been showing advancement. Speedy progressions in computational technologies have significantly accelerated the development of computer-aided drug design. Recently, pharmaceutical sector has gradually shifted its attention towards traditional system of medicine for getting insight into novel lead compounds and directed their efforts towards 3D small molecular structure database available for molecular simulation or virtual screening. In this chapter an attempt has been made to discuss existing methods for target prediction based on the bioactivity information from the ligand side as well as the methods that are applicable in circumstances when the structure of a protein is known. The detailed account of in silico target identification applications based partly/whole on computational target predictions has been described.


Nutraceuticals Phytochemicals In silico Chemoinformatics 



Ramesh Kumar and Amit Kumar Singh acknowledges financial support from CSIR New Delhi, India, in the form of Junior Research Fellowship and Ashutosh Gupta acknowledges financial support from UGC-CRET New Delhi, India. All the authors also acknowledge DST-FIST and UGC-SAP facility of Department of Biochemistry University of Allahabad, Allahabad India.


  1. Adhami HR, Linder T, Kaehlig H. Catechol alkenyls from Semecarpus anacardium: acetylcholinesterase inhibition and binding mode predictions. J Ethnopharmacol. 2012;139:142.CrossRefGoogle Scholar
  2. Barden CJ, Weaver DJ. The rise of micropharma. Drug Discov Today. 2010;15:84–7.CrossRefGoogle Scholar
  3. Chen X, Ung CY, Chen Y. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? Nat Prod Rep. 2003;20:432.CrossRefGoogle Scholar
  4. Dhiman V, Singh DK, Ladumor MK. Characterization of stress degradation products of amodiaquinedihydrochloride by liquid chromatography with high-resolution mass spectrometry and prediction of their properties by using ADMET predictor. J Sep Sci. 2017;40:4530–40.CrossRefGoogle Scholar
  5. Do QT, Renimel I, Andre P. Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of epsilon-viniferin. Curr Drug Discov Technol. 2005;2:161–7.CrossRefGoogle Scholar
  6. Eldehna WM, Fares M, Ibrahim HS. Synthesis and cytotoxic activity of biphenylurea derivatives containing indolin-2-one moieties. Molecules. 2016;21:E762.CrossRefGoogle Scholar
  7. Fowler AK, Outsioni Y, Sommer V. Leaf-swallowing in Nigerian chimpanzees: evidence for assumed self-medication. Primates. 2007;48:73–6.CrossRefGoogle Scholar
  8. Hardy B, Douglas N, Helma C. Collaborative development of predictive toxicology applications. J Cheminform. 2010;2:7.CrossRefGoogle Scholar
  9. Kerns EH, Li D. Drug-like properties: concepts, structure design and methods. Oxford: Elsevier Ltd.; 2008. p. 125–36.Google Scholar
  10. Kesavan R, Potunuru UR, Nastasijevi B. Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts. PLoS One. 2013;8:61393.CrossRefGoogle Scholar
  11. Krief S, Jamart A, Mahe S. Clinical and pathologic manifestation of oesophagostomosis in African great apes: does self-medication in wild apes influence disease progression? J Med Primate. 2008;37:188–95.CrossRefGoogle Scholar
  12. Lagunin AA, Goel RK, Gawande DY. Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. Nat Prod Rep. 2014;31:1585–611.CrossRefGoogle Scholar
  13. Lakshmi Ranganatha V, Zameer F, Meghashri S. Design, synthesis and anticancer properties of novel benzophenone conjugated coumarinanalogs. Arch Pharm. 2013;346:901–11.CrossRefGoogle Scholar
  14. Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol. 1996;6:402–6.CrossRefGoogle Scholar
  15. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.CrossRefGoogle Scholar
  16. Maurya A, Khan F, Bawankule DU, et al. QSAR, docking and in vivo studies for immunomodulatory activity of isolated triterpenoids from Eucalyptus tereticornis and Gentiana kurroo. Eur J Pharm Sci. 2012;47:152–61.CrossRefGoogle Scholar
  17. Meena A, Yadav DK, Srivastava A. In silico exploration of anti-inflammatory activity of natural coumarinolignoids. Chem Biol Drug Des. 2011;78:567–79.CrossRefGoogle Scholar
  18. Pan SY, Gao SH, Zhou SF, et al. New perspectives on complementary and alternative medicine: an overview and alternative therapy. Altern Ther Health Med. 2012;18:20–36.PubMedGoogle Scholar
  19. Puppala M, Ponder J, Suryanarayana P. The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS One. 2012;7:31399.CrossRefGoogle Scholar
  20. Qidwai T, Yadav DK, Khan F. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Curr Pharm Des. 2012;18:6133–55.CrossRefGoogle Scholar
  21. Santhi N, Aishwarya S. Insights from the molecular docking of with anolide derivatives to the target protein PknG from Mycobacterium tuberculosis. Bioinformation. 2011;7:1–4.CrossRefGoogle Scholar
  22. Schippmann U, Cunningham AB, Leaman DJ. Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. Rome: FAO; 2002. p. 142–67.Google Scholar
  23. Shah BA, Chib R, Gupta P. Saponins as novel TNF-α inhibitors: isolation of saponins and a nor-pseudoguaianolide from Parthenium hysterophorus. Org Biomol Chem. 2009;7:3230–5.CrossRefGoogle Scholar
  24. Sharma S, Chattopadhyay SK, Yadav DK. QSAR, docking and in vitro studies for anti-inflammatory activity of cleomiscosin A methyl ether derivatives. Eur J Pharm Sci. 2012;47:952.CrossRefGoogle Scholar
  25. Vaishnavi K, Saxena N, Shah N. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences. PLoS One. 2012;7:44419.CrossRefGoogle Scholar
  26. Valerio LG Jr. Application of advanced in-silico methods for predictive modeling and information integration. Exp Opin Drug Metab Toxicol. 2012;8:395–8.CrossRefGoogle Scholar
  27. Van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2:192–204.CrossRefGoogle Scholar
  28. Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615–23.CrossRefGoogle Scholar
  29. Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8:1555–72.CrossRefGoogle Scholar
  30. Willmann S, Lippert J, Schmitt W. From physicochemistry to absorptionand distribution: predictive mechanistic modelling and computational tools. Exp Opin Drug Metab Toxicol. 2005;1:159–68.CrossRefGoogle Scholar
  31. Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med. 1998;158:2192–9.CrossRefGoogle Scholar
  32. Wu M, Atchley D, Greer L, et al. Dosed without prescription: preventing pharmaceutical contamination of our nation’s drinking water. Environ Sci Technol. 2011;15:366–7.CrossRefGoogle Scholar
  33. Yadav DK, Meena A, Srivastava A, et al. Development of QSAR model for immunomodulatory activity of natural coumarinolignoids. Drug Des Dev Ther. 2010;4:173–86.Google Scholar
  34. Yadav DK, Khan F, Negi AS. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J Mol Model. 2012;18:2513–25.CrossRefGoogle Scholar
  35. Yi F, Sun L, Xu LJ, et al. In silico approach for anti-thrombosis drug discovery: P2Y1R structure-based TCMs screening. Front Pharmacol. 2016;7:531.CrossRefGoogle Scholar
  36. Yi F, Li L, Xu LJ, et al. In silico approach in reveal traditional medicine plants pharmacological material basis. Chin Med. 2018;13:33.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Ramesh Kumar
    • 1
  • Amit Kumar Singh
    • 1
  • Ashutosh Gupta
    • 1
  • Abhay K. Pandey
    • 1
  1. 1.Department of BiochemistryUniversity of AllahabadAllahabadIndia

Personalised recommendations